Novel Doppler assessment of intracoronary volumetric flow reserve: Validation against PET in patients with or without flow-dependent vasodilation

Journal of Nuclear Medicine

Volumn 46, Issue 8, 2005, Pages 1272-1277

  Kaufmann, Philipp A ^a   Namdar, Mehdi ^a   Matthew, Felix ^a   Roffi, Marco ^a   Aschkenasy, Schlomo V ^a   Van Der Loo, Bernd ^a   Sutsch, Gabor ^a   Lüscher, Thomas F ^a   Jenni, Rolf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Coronary flow reserve; Intracoronary Doppler guidewire; Myocardial blood flow; PET

Indexed keywords

ADENOSINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOPPLER FLOWMETRY; FEMALE; GATED IMAGING; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; INTERMETHOD COMPARISON; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VALIDATION STUDY; VASODILATATION; BLOOD VOLUME; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DRUG EFFECT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD VOLUME DETERMINATION; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL; VASODILATOR AGENTS;

EID: 25444511083     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Campisi R, Czemin J, Schröder H, Sayre JW, Schelbert HR. L-Arginine normalizes coronary vasomotion in long-term smoker. Circulation 1999;99:491-497.
2. Kaufmann PA, Gneschi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233-1238.
3. Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation 1999;99:475-481.
4. Kaufmann PA, Gneschi-Ruscone T, Schafers KP, Luscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-109.
5. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a mechanism for angina pectons in patients with arterial hypertension and normal coronary arteries. Circulation 1984;69:1-7.
6. Di Carli MF, Bianco-Batlles D, Landa ME, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999;100:813-819.
7. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med 2005;46:75-88.
8. De Bruyne E, Pijls NH, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: experimental validation. Circulation 2001;104:2003-2006.
9. Nichols WW, O'Rourke MF. The nature of flow of a fluid. In: Nichols WW, O'Rourke MF, eds. McDonald's Blood Flow in Arteries 3rd ed. London, U.K.: Edward Arnold; 1990:12-53.
10. Jenni R, Kaufmann PA, Jiang Z, Attenhofer C, Linka A, Mandinov L. In vitro validation of volumetric blood flow measurement using Doppler flow wire. Ultrasound Med Biol 2000;26:1301-1310.
11. Jenni R, Matthews F, Aschkenasy SV, et al. A novel in vivo procedure for volumetnc flow measurements. Ultrasound Med Biol 2004;30:633-637.
12. Mandinov L, Kaufmann P, Staub D, Buckingham TA, Amann FW, Hess OM. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the seventy of the culprit lesion. J Am Coll Cardiol 1997;30:682-688.
13. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384-389.
14. 15O-labeled water and PET. J Nucl Med 1999;40:1848-1856.
15. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med 2003;44:146-154.
16. Challis RE, Kitney RI. Biomedical signal processing (in four parts). Part 2. The frequency transform; and their inter-relationships. Med Biol Eng Comput 1991;29:1-17.
17. Kaufmann P, Vassalli G, Utzinger U, Hess OM. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol 1995;26:624-631.
18. Kaufmann P, Mandinov L, Hess OM. Coronary stenosis vasoconstriction: impact on myocardial ischaemia. Eur Heart J 1997;18:1853-1859.
19. Kaufmann PA, Frielingsdorf J, Mandinov L, Seiler C, Hug R, Hess OM. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia. Circulation 1998;97:1348-1354.
20. 15O blood pool scan. J Nucl Med 1998;39:1696-1702.
21. Kaufmann PA, Schirlo C, Pavhcek V, et al. Increased myocardial blood flow during acute exposure to simulated altitudes. J Nucl Cardiol 2001;8:158-164.
22. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. Influence of altitude exposure on coronary flow reserve. Circulation 2003;108:1202-1207.
23. Koepfli P, Hany TF, Wyss CA, et al. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med 2004;45:537-542.
24. Wyss CA, Koepfli P, Namdar M, et al. Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging 2005;32:84-91.
25. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.
26. Eland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:307-310.
27. Jagathesan R, Kaufmann PA, Rosen SD, et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med 2005;46:212-219.
28. Kaufmann PA, Jenni R. Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution. J Am Coll Cardiol 2000;35:1363-1365.
29. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-824.
30. Zijlstra F, van Ommeren J, Reiber JH, Serruys PW. Does the quantitative assessment of coronary artery dimensions predict the physiologic significance of a coronary stenosis? Circulation 1987;75:1154-1161.
31. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-2342.
32. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Am J Cardiol 1974;33:87-92.
33. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:459-474.
34. Each RG, Donohue TJ, Kern MJ. Intracoronary Doppler flow velocity measurements for the evaluation and treatment of coronary artery disease. Curr Opin Cardiol 1995;10:434-442.
35. Sudhir K, Hargrave VK, Johnson EL, et al. Measurement of volumetric coronary blood flow with a Doppler catheter: validation in an animal model. Am Heart J. 1992;124:870-875.
36. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-1911.
37. Labovitz AJ, Anthonis DM, Cravens TL, Kern MJ. Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wire. Am Heart J 1993;126:1456-1461.
38. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothehum-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-356.
39. Rossen JD, Quillen JE, Lopez AG, Stenberg RG, Talman CL, Winniford MD. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991;18:485-491.
40. Rossen JD, Oskarsson H, Minor RL, et al. Effect of adenosine antagonism on metabolically mediated coronary vasodilation in humans. J Am Coll Cardiol 1994;23:1421-1426.
41. Jenni R, Buchi M, Zweifel HJ, Ritter M. Impact of Doppler guidewire size and flow rates on intravascular velocity profiles. Cathet Cardiovasc Diagn 1998;45:96-100.